Today Renapharma is a family-owned pharmaceutical company operated under the leadership of CEO Caroline Danielson and Kristin Danielson, who is currently researching iron metabolism at the Karolinska Institute. Through comprehensive scientific studies and trials, Renapharma is developing medications, dietary supplements and medical technology in order that the company benefits society through long-term improvements to people’s lives and health.
Renapharma
Renapharma offers high-quality medications in addition to dietary supplements.
